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Regulation and Destabilization of HIF-1
by ARD1-Mediated Acetylation
quitin-proteasome pathway (Salceda and Caro, 1997;
Huang et al., 1998; Maxwell et al., 1999; Berra et al.,
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Phosphorylation and dephosphorylation in the signal-
ing pathway can result in HIF-1 activation (Richard et al.,
1999). During hypoxia, p42/p44 MAPK activity inducesSummary
posttranslational phosphorylation of HIF-1 and pro-
motes the transcriptional activity of HIF-1 (Richard etHypoxia-inducible factor 1 (HIF-1) plays a central role
al., 1999). According to a recent report, the hydroxylationin cellular adaptation to changes in oxygen availability.
of asparagine (Asn803), located in the C-terminal trans-Recently, prolyl hydroxylation was identified as a key
activation domain (C-TAD) of HIF-1, inhibits interactionregulatory event that targets the HIF-1 subunit for
with the p300/CBP coactivator and reduces the tran-proteasomal degradation via the pVHL ubiquitination
scriptional activity of HIF-1 during normoxic conditionscomplex. In this report, we reveal an important func-
(Hewitson et al., 2002; Lando et al., 2002a, 2002b).tion for ARD1 in mammalian cells as a protein acetyl-
Thus, the modulation of HIF-1 stability and its activa-transferase by direct binding to HIF-1 to regulate its
tion involve multiple proteins and several posttransla-stability. We present further evidence showing that
tional modifications. Until recently, studies of posttrans-ARD1-mediated acetylation enhances interaction of
lational modifications of HIF-1 were restricted toHIF-1 with pVHL and HIF-1 ubiquitination, sug-
hydroxylation, ubiquitination, and phosphorylation.gesting that the acetylation of HIF-1 by ARD1 is criti-
Other posttranslational modifications of HIF-1 have notcal to proteasomal degradation. Therefore, we have
been defined.concluded that the role of ARD1 in the acetylation of
In the present study, we used the yeast two-hybridHIF-1 provides a key regulatory mechanism underly-
system to identify proteins that interact with the ODDing HIF-1 stability.
domain of HIF-1. One of the HIF-1-interacting clones,
mouse ARD1, shares 57% identity with the ARD1 acetyl-
Introduction
transferase sequence of Saccharomyces cerevisiae
(Tribioli et al., 1994). ARD1 is required for the expression
Eukaryotic cells sense oxygen and adapt to hypoxia by of protein N-acetyltransferase (NAT) activity in lower
regulating a number of genes. In mammalian cells, the eukaryotes and bacteria (Tribioli et al., 1994; Park and
transcriptional complex HIF-1 plays an essential role in Szostal, 1992; Ingram et al., 2000). However, its function
cellular and systemic oxygen homeostasis (Iyer et al., in mammalian cells has not been defined.
1998; Semenza, 2000). HIF-1 stimulates the transcription Acetylation is a posttranslational modification of pro-
of genes, such as erythropoietin and VEGF, whose pro- teins, with histones the best-known example (Kou-
tein products function to either increase oxygen avail- zarides, 2000). Several enzymes are reported as histone
ability by promoting erythropoiesis and angiogenesis, acetyltransferases; these include PCAF, p300/CBP,
or activates genes involved in glucose transport and SRC1, and MOZ (Kouzarides, 1999). Recently, these
metabolism (Semenza, 1999). acetyltransferases have been shown to modify other
HIF-1 is composed of two subunits: the hypoxia-regu- proteins besides histones, including general transcrip-
lated  subunit, HIF-1, and the oxygen-insensitive HIF- tion factors, e.g., E2F1, MyoD, GATA-1, and p53 (Kou-
1 subunit (Wang et al., 1995). Under normoxia, the HIF- zarides, 2000; Ogryzko et al., 1998; Boyes et al., 1998).
1 subunit is rapidly degraded via the von Hippel-Lindau Similar to phosphorylation, the posttranslational modifi-
tumor suppressor gene product (pVHL)-mediated ubi- cation of general transcription factors by acetylation can
regulate their DNA binding activity and interaction with
other proteins such as coactivator proteins and tran-4 Correspondence: qwonkim@plaza.snu.ac.kr
Cell
710
Figure 1. ARD1 Interacts with HIF-1 In Vitro
and In Vivo
(A) Structures of HIF-1 and its derivatives
are schematically shown. Gray boxes repre-
sent the ODD domain. 1, Full-length HIF-1,
1–827 aa ; 2, 1–603 aa; 3, 1–400 aa; 4, 401–603
aa; 5, 401–827 aa; and 6, 604–827 aa.
(B) HIF-1 and its deletion derivatives were
translated by programmed reticulocyte lysate
in the presence of [35S]methionine. 10% of
the material used in the GST pull-down exper-
iment is shown (left). In vitro translated pro-
teins were mixed with GST-ARD1 bound
beads (middle) or GST bound beads (right),
and a GST pull-down assay was performed.
The numbers at the bottom indicate the deriv-
atives of HIF-1 shown in (A).
(C) HEK293 cells were transfected with ex-
pression vector for CMV-ARD1 and/or GFP-
HIF-1 as indicated. After 24 hr posttransfec-
tion, the cells were incubated under hypoxia
and the cell extracts were prepared. Total cell
lysates were immunoprecipitated with anti-
FLAG antibody. The presence of GFP-HIF-
1 in the immunoprecipitates was examined
using anti-HIF-1 antibody (top). Arrowheads
at left indicate nonspecific bands. Immuno-
precipitated materials and total cell extracts
were analyzed by Western blots with anti-
Flag antibody and anti-HIF-1 antibody, re-
spectively (middle, bottom). The relative in-
teractions from three independent assays
were quantified by densitometry. The interac-
tion of ARD1 with HIF-1 under normoxia was
set to 100% (right). IP, immunoprecipitation;
N, normoxia, 21% O2; H, hypoxia, 1% O2.
scriptional regulator proteins (Bannister and Miska, clones were isolated and 64 clones were further selected
2000; Barlev et al., 2001). However, studies of protein by -galactosidase assays in another yeast strain, SFY
acetyltransferases, except for histone acetyltransfer- 526, containing a GAL1UAS-LacZ reporter gene.
ases, and their substrates are in an early stage. DNA sequencing and database searches revealed
In this report, we established the function of ARD1 as that the nucleotide sequences of 13 clones (5 clones
a protein acetyltransferase in mammalian cells, with HIF- from a 17 day embryonic mouse cDNA library and 8
1 a possible target protein for the enzyme. Moreover, clones from mouse T cell cDNA library) correspond to
we show that the acetylation of HIF-1 by ARD1 regulates a 700 bp mouse cDNA of a mouse homolog for ARD1
the stability of HIF-1 in response to O2 concentration and N-acetyltransferase (GenBank accession number
further demonstrate that the acetylation of HIF-1 by NM_019870). This gene, called mouse ARD1 in GenBank
ARD1 can be coordinated with other posttranslational databases, has 96% homology to the human homolog
modifications, prolyl hydroxylation, and ubiquitination. ARDH (NM_003491) and 57% homology to S. cerevisiae
ARD1 (M11621).
Direct interaction of ARD1 with HIF-1 in vitro wasResults
examined using GST pull-down assays. We synthesized
35S-labeled deletion constructs of HIF-1 (Figure 1A) inIdentification of ARD1 for HIF-1-Interacting Protein
vitro, then tested for interactions with bacterially ex-We used the yeast two-hybrid system to identify candi-
pressed glutathione-S-transferase (GST) or GST-fuseddate proteins that interact with HIF-1 in vivo. To per-
ARD1. The results shown in Figure 1B indicated thatform the two-hybrid assay, the his yeast strain HF7C
three deletion constructs, including the ODD domain,was cotransformed with a bait vector, encoding the
(HIF-1 1–603, 401–603, 401–827) and the full-lengthGAL4 DNA binding domain in-frame with HIF-1 resi-
HIF-1 were pulled down by interaction with the GST-dues 401–603 (ODD domain) (Huang et al., 1998) and
fused ARD1 protein, whereas the amino acid 1–400 andprey vectors, allowing expression of mouse embryonic
604–827 regions of HIF-1 showed no interactions.and T cell lymphoma cDNA sequences in-frame with
None of the HIF-1 constructs used in this assay boundGAL4 transactivation domain. The bait did not show any
GST alone.self-activity of transcriptional activation for the report-
Interaction between ARD1 and HIF-1 in vivo wasers. We screened 6  106 yeast transformants for histi-
confirmed by coimmunoprecipitation assays. To over-dine auxotrophy and -galactosidase expression. From
these transformants, 190 His/Lac double-positive express the ARD1 and HIF-1 proteins in HEK 293 cells,
ARD1 Acetylates and Destabilizes HIF-1
711
Figure 2. ARD1 Decreases the HIF-1-Medi-
ated Transactivation Function and VEGF Ex-
pression
(A) HEK293 cells were cotransfected with
pSV40pro-EpoHRE-Luc (1 g) or mutated
EpoHRE-Luc (1 g), pBOS-hHIF-1 (0.1 g),
pBOS-hARNT (0.1g), or pEF-BOS alone (0.2
g) and 2 g of pCMV-ARD1 or pCMV alone
as indicated. Transfected cells were incu-
bated for 24 hr at 21% O2 and then incubated
at 21% O2 or 1% O2 for an additional 16 hr.
The mean and standard deviation based on
three (mutated EpoHRE) or six (wild-type
EpoHRE) independent transfections are
shown.
(B) HT1080 cells were stably transfected with
the indicated expression vector and left un-
treated or exposed to 1% O2 for 16 hr. RT-
PCR analysis (top two) was performed to de-
tect gene expression using specific primer
for VEGF and -actin. Anti-VEGF and anti-
-tubulin Western blots from total protein ex-
tracts (bottom two) were performed. The
VEGF mRNA expression level was measured
in four independent experiments followed by
densitometry. The expression under nor-
moxia was set to 100% (right).
we cotransfected the Flag-tagged ARD1 expression designated as HT1080-ARD1 cells. As shown in Figure
2B, the increased expressions of VEGF mRNA and pro-vector and the GFP-HIF-1 expression vector into HEK
293 cells. When the Flag-ARD1 protein was immunopre- tein by hypoxia were downregulated in HT1080-ARD1
cells. These results suggest that the ARD1 protein nega-cipitated from transfected cell extracts using the anti-
-Flag antibody, the GFP-HIF-1 protein was coimmu- tively regulates the hypoxia-inducible transcriptional ac-
tivity of HIF-1.noprecipitated (Figure 1C). ARD1 interacted with HIF-1
under both normoxic and hypoxic conditions; however,
this interaction was decreased when cells were exposed ARD1 Downregulates HIF-1 Protein Stability
to 1% O2, in spite of the higher GFP-HIF-1 expression Since the ARD1 protein directly binds to the ODD do-
level under this condition (Figure 1C). main, we examined the effect of ARD1 on HIF-1 protein
stability. As shown in Figure 3A, the overexpressed
ARD1 downregulated the protein level of HIF-1 inducedARD1 Inhibits Transcriptional Activation
Mediated by HIF-1 by hypoxia, but it did not affect mRNA level of HIF-1,
suggesting that the reduction of the HIF-1 protein levelTo investigate whether ARD1 protein is involved in HIF-1
transcriptional activity, we used a luciferase reporter by ARD1 was not due to the transcriptional reduction
of the HIF-1 gene. This suggests that the stability ofsystem, pSV40promoter-EpoHRE-Luc, and mutated
EpoHRE-Luc reporters. Upon transient transfection of the HIF-1 protein is reduced by ARD1 protein.
To confirm this notion, we added MG132, a specificHIF-1, ARNT, and EpoHRE-Luc vectors, reporter activ-
ity was markedly increased in cells exposed to 1% O2 inhibitor of the 26S proteasome, to HT1080-ARD1 cells
and checked the level of HIF-1 protein. In the presence(Figure 2A). However, the overexpression of ARD1 was
shown to decrease the transcriptional activity of HIF-1 of MG132, the HIF-1 protein level decreased by ARD1
was restored to the level of hypoxia-treated HT1080in a dose-dependent manner. In cells transfected with
the mutated EpoHRE reporter, luciferase activity was cells (Figure 3B). Furthermore, in pulse-chase experi-
ments, the half-life of the HIF-1 protein was decreasednot changed by either hypoxia or the ARD1 protein.
Furthermore, to evaluate whether ARD1 modulates in HT1080-ARD1 cells compared to HT1080 cells,
thereby confirming the effect of ARD1 on the downregu-the hypoxia-response element (HRE)-containing VEGF
gene, HT1080 cells were stably transfected with the lation of HIF-1 stability (Figure 3C).
The downregulation of the HIF-1 protein level byFlag-tagged ARD1 expression vector, pCMV-ARD1.
HT1080 cells overexpressing the ARD1 protein were ARD1 under normoxic conditions was undetectable be-
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Figure 3. ARD1 Decreases HIF-1 Stability
and Regulates Association between HIF-1
and pVHL
(A) HT1080 and HT1080-ARD1 cells were ex-
posed to 1% or 21% O2 for 2 hr. HIF-1 pro-
tein levels and mRNA levels were examined
by Western blot analysis (top two) and RT-
PCR analysis (bottom two), respectively. The
relative HIF-1 protein level from six indepen-
dent assays was quantified by densitometry.
The HIF-1 protein level under hypoxia was
set to 100% (right).
(B) HIF-1 protein in HT1080 and HT1080-
ARD1 cells exposed to 1% O2 for 2 hr followed
by the addition of 5 M MG132 for 1 hr as
indicated. Cell lysates were harvested and
subjected to immunoblot analysis of HIF-1.
(C) HT1080 (open circles) and HT1080-ARD1
(closed circles) cells were pulse labeled with
[35S]methionine and chased in unlabeled me-
dium for the indicated times under hypoxia.
Cell lysates were immunoprecipitated with
anti-HIF-1 antibody. The intensities of HIF-
1 signals from three independent experi-
ments were quantified and plotted.
(D) HEK293 cells were transfected with the
antisense ARD1 expression vector and left
untreated or exposed to 1% O2 for 2 hr. HIF-
1 protein levels by Western blot were exam-
ined (top two) and diminished ARD1 mRNA
by the antisense ARD1 expression vector was
checked using RT-PCR (bottom two).
(E) Endogenous pVHL was immunoprecipi-
tated from 5 M MG132 treated HT1080 and
HT1080-ARD1 cell extracts with anti-pVHL
antibody, and coprecipitated HIF-1 was de-
tected by Western blot analysis. Immunopre-
cipitated pVHL was visualized by Western
blot analysis with anti-pVHL antibody for
loading control (bottom). The relative interac-
tion from three independent experiments was
quantified by densitometry. The interaction
of HIF-1 with pVHL in HT1080 cells was set
to 100% (bottom).
cause HIF-1 is not present in this condition. However, activity of ARD1, we first assessed whether stimulated
HIF-1 stability under normoxia was significantly in- acetylation affects the protein level of HIF-1. To do
creased by transfection of the antisense ARD1 expres- that, we treated HT1080 cells with sodium butyrate, an
sion vector (Figure 3D). These data strongly suggest inhibitor of protein deacetylases. As shown in Figure 4A,
that endogenous ARD1 induces the degradation of HIF- sodium butyrate dramatically decreased the hypoxia-
1 under normoxia. Similarly, HIF-1 stability under hyp- induced HIF-1 protein level. A histone deacetylase in-
oxia was increased by the antisense ARD1 expression hibitor, TSA, also decreased the expression of HIF-1
vector. protein (Figure 4A). These results suggest that the deg-
In addition, we investigated whether ARD1 partici- radation of HIF-1 is stimulated by protein acetylation.
pates in the association of HIF-1 and pVHL, which To obtain in vivo evidence showing the acetylation of
negatively regulates HIF-1 stability. We found that un- HIF-1protein, we transfected HIF-1 expression vector
der normoxic conditions, ARD1 overexpression in- into HEK 293 cells and performed an in vivo acetylation
creased interaction of HIF-1 with pVHL (Figure 3E). assay using an anti-Ac-Lys antibody. The results shown
These results suggest that ARD1 could function as a in Figure 4B indicate that lysine residue(s) in ectopic
negative regulator of HIF-1 stability by accelerating the HIF-1 was acetylated in vivo and that this acetylation
recruitment of pVHL to HIF-1. was stimulated by the overexpression of the ARD1
protein.
Next, we examined the relative acetylated HIF-1 un-ARD1 Acetylates the ODD Domain of HIF-1
der normoxic and hypoxic conditions, because the rateThe function of the ARD1 protein as an acetyltransferase
of HIF-1 acetylation may be not equal under theseis known in lower eukaryotes, such as S. cerevisiae;
conditions. Although tests revealed that the protein levelhowever, the function and the substrates of ARD1 in
of HIF-1 was almost the same under these two condi-mammalian cells have not been identified. To determine
if HIF-1 can be acetylated by the acetyltransferase tions when treated with MG132, the acetylation level of
ARD1 Acetylates and Destabilizes HIF-1
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Figure 4. ARD1 Acetylated the ODD Domain
of HIF-1
(A) HT1080 cells were exposed to 1% O2 for
2 hr with addition of 10 mM NaBu or 300 ng/ml
TSA as indicated. Cell lysates were harvested
and subjected to immunoblot analysis of HIF-
1. The relative HIF-1 protein level from four
independent assays was quantified by densi-
tometry. The HIF-1 protein level under hyp-
oxia was set to 100% (right).
(B) For ectopic expression of HIF-1, HEK293
cells were transfected with pBOS-hHIF-1
expression vector. Extracts were immuno-
precipitated with anti-Ac-Lys antibody, and
immunoprecipitates were subjected to West-
ern blot analysis for HIF-1. The relative acet-
ylated HIF-1, the acetylated HIF-1/
expressed HIF-1 ratios, was normalized to
the results of immunoprecipitation and West-
ern blot analysis using densitometer from
three independent assays (right).
(C) HT1080 cells were exposed to 5 M
MG132 or 1% O2 for 2 hr as indicated and
cell lysates were immunoprecipitated with
anti-Ac-Lys antibody. Cell lysates and immu-
noprecipitates were subjected to Western
blot analysis with anti-HIF-1 antibody. The
relative acetylated HIF-1, the acetylated
HIF-1/expressed HIF-1 ratios, was normal-
ized to the results of immunoprecipitation and
Western blot analysis from five independent
assays (right).
(D) Following incubation of purified ODD do-
main (400 ng) with 50 nCi [14C]acetyl-CoA (top)
or 10 mM acetyl-CoA (middle) and 100 ng of
purified ARD1 protein for 2 hr at 30C, the
reaction products were separated by SDS-
PAGE and visualized by autoradiography
(top) and Western blot analysis with anti-Ac-
Lys antibody (middle). The input ODD domain
proteins were shown using Coomassie bril-
liant blue staining (bottom).
HIF-1 in normoxia was much higher than that of HIF-1 and Roeder, 1997). There are six lysine residues in the
ODD domain of HIF-1, namely K443, K460, K477, K532,in hypoxia or under a MG132-treated hypoxic condition
(Figure 4C). K538, and K547. To identify the acetylated lysine(s) of
the ODD domain by ARD1, we performed site-directedOur next question to answer was whether HIF-1
could serve as a direct substrate for ARD1 and whether mutagenesis using pET-ODD expression vector to
change the six single lysines to arginine residues. TheARD1 protein can function as a HIF-1 acetyltransferase
by direct interaction with the ODD domain. To test these six mutated ODD proteins were purified and an in vitro
acetyltransferase assay was executed. Interestingly, aspossibilities, we performed an in vitro acetyltransferase
assay using purified recombinant ODD and ARD1 pro- shown in Figure 5A, ODD-K532R was not acetylated by
ARD1. However, the other mutated ODD proteins (ODD-teins. As shown in Figure 4D, lysine residues of the ODD
domain were acetylated in the presence of ARD1 protein K443R, -K460R, -K477R, -K538R, and -K547R) were
acetylated to a similar level as the wild-type ODD pro-and Ac-CoA, whereas acetylated ODD was not detected
in the absence of either ARD1 or Ac-CoA. These results tein. Therefore, we suggest that ARD1 protein specifi-
cally acetylates Lys532 in the ODD domain of HIF-1.strongly suggest that the ARD1 protein acetylates the
ODD domain of HIF-1 by transferring acetyl group from To confirm the acetylation site of the ODD domain,
the in vitro acetylated ODD protein by ARD1 protein wasAc-CoA to lysine residues in the ODD domain through
direct interaction. purified by immunoprecipitation with Ac-Lys antibody
and digested with V8 protease, and then the resulting
peptides were analyzed using a matrix-assisted laserARD1 Acetylates the Lys532 in HIF-1 Protein
desorption/ionization time-of-flight mass spectrometryIn general, the position-specific acetylation of a target
protein is mediated by distinct acetyltransferases (Gu (MALDI-TOF MS). The masses of these peptides were
Cell
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Figure 5. The Acetylation Site of HIF-1 by
ARD1 Is Lys532 in ODD Domain
(A) Purified recombinant ODD and mutated
ODD domain proteins were incubated with
acetyl-CoA and ARD1 protein for acetylation
reaction. In vitro acetylated proteins were
subjected to Western blot analysis with anti-
Ac-Lys antibody. 10% of the materials used
in this assay was shown by staining with Coo-
massie brilliant blue (bottom).
(B) In vitro acetylated ODD protein with ace-
tyl-CoA and ARD1 was purified using anti-
Ac-Lys antibody and cleaved with V8 prote-
ase, and then was subjected to MALDI-TOF
MS. The arrow indicated the acetylated pep-
tide peak.
(C) Sequence alignments of human and
mouse HIF- proteins. The asterisk denotes
the lysine residue that acts as a target for
ARD1-induced acetylation. Two dots denote
the conserved prolines (Pro402 and Pro564)
for hydroxylation.
compared with masses of expected peptides calculated As shown in Figure 6A, the transfected HIF-1-K532R
protein was stable in normoxia, whereas wild-type HIF-from the known sequence (Figure 5B). New peptide at m/z
1580.7529 Da was detected in the ODD domain acetylated 1 was degraded under the same condition. To deter-
mine the half-life of the HIF-1-K532R protein, we per-by ARD1 protein. This is the expected mass of acetylated
(42.0106 Da increase) 525-SDMVNVFKLELVE-537 peptide formed pulse-chase experiments using transiently
transfected HEK293 cells under normoxia. The resultscontaining oxidation of Met (15.9950 Da increase) (Fig-
ure 5B). This result confirmed the target site of ARD1 confirmed that HIF-1-K532R protein is more stable
than wild-type HIF-1 protein under normoxia (Figureas Lys532 in HIF-1.
It is worth noting that this lysine residue is conserved 6A). Moreover, the interaction of pVHL with HIF-
1-K532R protein was much weaker than that with wild-in HIF-1 and -2, which are oxygen sensitive, whereas
HIF-3, stable even in normoxia (Hara et al., 2001), does type protein (Figure 6B). These results suggested that
HIF-1-K532R protein is stable under normoxic condi-not contain this residue (Figure 5C). However, two pro-
line residues for hydroxylation are conserved in the three tions when pVHL interaction is reduced.
Based on the finding that the K532R mutant proteinHIF- proteins.
was not acetylated by ARD1, we expected that the acet-
ylation of Lys532 in HIF-1 stimulates the degradation
of this protein through increasing pVHL-mediated ubi-ARD1 as a HIF-1 Acetyltransferase Stimulates
HIF-1 Degradation quitination. To examine this possibility, we first per-
formed a pull-down assay to test for the interactionAs described above, Lys532 is the target site for acetyla-
tion by ARD1 protein, and ARD1 decreased the stability between the ODD domain and pVHL. As shown in Figure
6C, ARD1-treated (acetylated) wild-type ODD proteinof HIF-1. In a previous report, a Lys532-mutated N-ter-
minal transactivation domain (N-TAD) of HIF-1 was not increased the interaction with pVHL, whereas ARD1-
treated ODD-K532R mutant protein did not.degraded under normoxic conditions (Tanimoto et al.,
2000). The authors suggested that Lys532 is critical to To test whether acetylation by ARD1 can stimulate
HIF-1 ubiquitination, we performed an in vitro ubiquiti-the degradation of HIF-1 protein. Since Lys532 is the
acetylation site, we suggest that the acetylation of nation assay using purified ODD protein. The result in
Figure 6D indicates that acetylation by ARD1 increasedLys532 by ARD1 is actively involved in the degradation
of HIF-1 under normoxic conditions. ubiquitination of the ODD domain. Moreover, the ODD-
K532R mutant protein was ubiquitinated at the sameTo prove this point, we transfected the Flag-tagged
HIF-1-K532R expression vector into HEK 293 cells and level as the wild-type, implying that Lys532 is not a
ubiquitination site (Figure 6E). In addition, we observedchecked the protein level under normoxic conditions.
ARD1 Acetylates and Destabilizes HIF-1
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Figure 6. The HIF-1-K532R Mutant Is Not
Degraded under Normoxic Conditions
(A) Flag-tagged wild-type or mutant HIF-1
(substitution of Lys532 to Arg) was transiently
expressed in HEK293 cells and incubated un-
der normoxic or hypoxic conditions for 6 hr.
Cell extracts were prepared and subjected to
immunoblot analysis with anti-Flag antibody
(top two). Wild-type (open circles) and K532R
mutant (closed circles) HIF-1-transfected
HEK293 cells were pulse labeled with
[35S]methionine and chased in an unlabeled
medium for the indicated times under nor-
moxia. Cell lysates were immunoprecipitated
with anti-Flag antibody. The intensities of
Flag-HIF-1 signals from three independent
experiments were quantified and plotted.
(B) After transfection of HEK293 cells with the
indicated vectors, 5 M MG132 was added
for 2 hr and total cell extracts were isolated.
Endogenous pVHL was immunoprecipitated
and coprecipitated HIF-1 was detected by
Western blot analysis. The relative interaction
from three independent experiments was
quantified by densitometry. The interaction of
wild-type HIF-1 with pVHL was set to 100%
(bottom).
(C) Purified His-ODD or His-ODD-K532R pro-
tein was acetylated by ARD1 as indicated and
products were preincubated in the presence
of HeLa cell extract at 30C for 2 hr. Pull-
down reaction was performed with 35S-
labeled pVHL for 1 hr and precipitants were
subjected to SDS-PAGE and autoradiogra-
phy. The interaction signals from three inde-
pendent experiments were quantified (bottom).
(D) 35S-labeled ODD was acetylated by ARD1
as indicated and the products were preincu-
bated with HeLa cell extract. The in vitro ubi-
quitination assay was performed at 30C for
2 hr and the reaction products were sub-
jected to SDS-PAGE and autoradiography.
Levels of total and ubiquitinated ODD in the
second and third lanes from left were quanti-
fied by densitometery. The ratio of ubiquiti-
nated/total ODD was determined and normal-
ized to the result obtained in the second lane
to yield the relative HIF-1 ubiquitination
(right).
(E) 35S-labeled ODD and ODD-K532R were preincubated with HeLa cell extract. The in vitro ubiquitination assay was performed at 30C for
2 hr and the reaction products were subjected to SDS-PAGE and autoradiography.
the hydroxylation of Pro564 in the ODD domain under cle, and liver, suggesting that ARD1 is broadly ex-
pressed.ARD1-mediated acetylation by the MALDI-TOF MS anal-
ysis (data not shown). These results indicate that the To examine the expression level of ARD1 during hyp-
oxia, we performed reverse transcriptase PCR. Theacetylation of Lys532 by ARD1 protein is a key regulatory
event for the maximal degradation of HIF-1, mediated ARD1 mRNA level was decreased in cells exposed to
1% O2 and was also decreased when cells were treatedby the pVHL ubiquitination complex under proline hy-
droxylated conditions. with hypoxia-mimicking agents, cobalt chloride and
2,2-dipyridyl (Figure 7B).
Our next question was the relation between ARD1
ARD1 Expression Is Decreased mRNA reduction and HIF-1 stability. We therefore
under Hypoxic Conditions checked the mRNA level of ARD1 and the acetylation
The EST data from UniGene Cluster Mm. 5934 indicated and protein levels of HIF-1 after hypoxic exposure for
that mouse ARD1 is expressed in almost every cell type. 2 and 4 hr. As shown in Figure 7C, ARD1 mRNA level
To confirm the expression of ARD1 mRNA, we per- decreased upon exposure to hypoxia for 2 and 4 hr. The
formed Northern blot analysis of RNAs from various hu- acetylation of HIF-1 was also decreased in proportion
man tissues. As shown in Figure 7A, ARD1 was detected to the increase of hypoxic exposure, whereas the protein
level of HIF-1 was increased. These data support thein all tissues tested, including brain, heart, skeletal mus-
Cell
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Figure 7. ARD1 Expression Is Decreased un-
der Hypoxic Conditions
(A) The expression of hARD1 mRNA was de-
tected by Northern blot analysis using human
multiple-tissue blot. A human -actin probe
was used as a loading control.
(B) HT1080 cells were incubated for 2 hr under
hypoxic conditions or treated with 100 M
cobalt chloride and 100 M 2,2-dipyridyl.
RT-PCR analysis was performed using spe-
cific primers for ARD1 and -actin.
(C) mRNA and cell lysates were isolated from
HT1080 cells exposed to 1% O2 for 2 and 4
hr, then Northern blot analysis using specific
probe for ARD1 and -actin (top two), acet-
ylation assay for HIF-1 (middle), and West-
ern blot analysis for HIF-1 and -tubulin
(bottom two) were performed.
(D) The nuclear and cytosolic extracts were
prepared from HT1080 or HT1080-ARD1 cells
exposed to 1% or 21% O2 for 2 hr. Extracts
were subjected to Western blot analysis with
anti-Flag antibody. Arrowheads at left indi-
cate nonspecific bands (top). Immunoblotting
was used to confirm purity of nuclear and
cytosolic extracts using antisera against his-
tone H1 and -tubulin, respectively.
hypothesis that decreased expression of ARD1 causes tional modification by prolyl hydroxylation targets HIF-
increased HIF-1 stability by reduction of acetylation 1 to the pVHL ubiquitination complex, leading to rapid
under hypoxia. proteasomal degradation (Ivan et al., 2001; Jaakkola et
To obtain information on the subcellular localization of al., 2001).
ARD1 protein, we separately prepared nuclear extracts In this report, we show the interaction of ARD1 with
and cytosolic extracts of ARD1 transfected cells. ARD1 HIF-1 using the yeast two-hybrid system and charac-
protein was detected only in the cytosolic fraction, not terize ARD1 as an important regulator of HIF-1 stability.
in nucleus (Figure 7D), indicating that ARD1 may act on We found that binding of ARD1 to HIF-1 was stronger
HIF-1 in the cytosol. under normoxic conditions than under hypoxic condi-
tions. Moreover, forced expression of ARD1 diminished
HIF-1 protein stability, whereas inhibition of ARD1 ex-Discussion
pression by transfection with an antisense ARD1 expres-
sion vector significantly increased protein stability.The regulation of HIF-1 stability and its activity occur
These results strongly suggest that ARD1 functions asat multiple levels. The modulation of HIF-1 protein by
a negative regulator of the HIF-1 protein.interaction with other proteins is known to play an impor-
Moreover, we characterized ARD1 as a protein acetyl-tant role in its stabilization and activation. Recent work
with mammalian cells demonstrated that posttransla- transferase and HIF-1 protein as a substrate of ARD1.
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ARD1 protein was discovered originally in S. cerevisiae of Lys532 by ARD1 in the ODD domain is critical to the
as a component of the NAT complex and was found to proteasomal degradation of HIF-1. We found that a
have the ability to form a homodimer or heterodimer K532R mutant of HIF-1 was not acetylated by ARD1
with NAT1 protein in S. cerevisiae (Park and Szostal, protein, and that the mutant protein was stabilized and
1992). In mammalian cells, human ARD1 homolog was showed decreased interaction with pVHL during nor-
found in all tissues examined, although its functions and moxia. Moreover, acetylation of the ODD domain by
substrates have not been characterized (Tribioli et al., ARD1 increased the interaction with pVHL and stimu-
1994). lated ubiquitination of HIF-1 protein.
Recently, TbDn-1 was isolated in mouse and found Previously, Tanimoto et al. (2000) examined three ly-
to be homologous to the yeast NAT1 protein, a subunit sines (K532, K538, and K547) of N-TAD for degradation
of the N-acetyltransferase complex that functions with of HIF-1 during normoxia. These investigators showed
the ARD1 protein in S. cerevisiae (Gendron et al., 2000). that the K532R mutation stabilized HIF-1 during nor-
However, in mammalian cells, TbDn-1 alone shows ace- moxia, and accordingly suggested that Lys532 is critical
tyltransferase activity without ARD1 or other acetyl- for the degradation of HIF-1. Furthermore, HIF-1, -2,
transferases (Gendron et al., 2000). Similarly, we found and -3 have two conserved prolines that are target
that the ARD1 protein itself acts as an acetyltransferase sites for hydroxylation and pVHL binding in the ODD
without a partner acetyltransferase and regulates HIF- domain, whereas the lysine residue acetylated by ARD1
1 stability. In fact, we found that neither TbDn-1 nor is conserved only in HIF-1 and -2, not HIF-3. In a
mouse NAT-1 homolog affected the stability of HIF-1 previous report, HIF-1 and -2 were shown to be de-
protein in human cells (data not shown). From these graded under normoxic conditions, and protein levels
data, we suggest that ARD1 is a new mammalian acetyl- increased in response to hypoxia, whereas the level of
transferase. HIF-3 was not affected by O2 concentration (Hara et
Several families of acetyltransferases are known, in- al., 2001). Therefore, these data further support our find-
cluding PCAF/GCN5, p300/CBP, TAF250, SRC1, and ing that the acetylation of lysine residue plays a critical
MOZ (Kouzarides, 1999). These enzymes function as role in the degradation of HIF- proteins in response to
histone acetyltransferases and mainly exist in the nu- O2 concentration.
cleus; however, several nonhistone proteins, such as Moreover, we found that HIF-1-K532R was ubiquiti-
general transcription factors and DNA binding proteins, nated at the same level as wild-type HIF-1 and that its
have been identified as substrates for PCAF and/or binding to pVHL was not changed by ARD1. From these
p300/CBP (Kouzarides, 2000). Recently, the acetylation data, we suggest that Lys532 of HIF-1 is the target site
of lysine residues in transcription factors by PCAF or for acetylation by ARD1, not a ubiquitination site. We
p300/CBP has been described for p53 (Gu and Roeder, also found that the acetylation of Lys532 in HIF-1
1997), GATA-1 (Boyes et al., 1998; Hung et al., 1999), strongly increased the interaction with pVHL and in-
EKLF (Zhang and Bieker, 1998), MyoD (Sartorelli et al., duced pVHL-mediated ubiquitination.
1999), TCF (Waltzer and Bienz, 1998), E2F1 (Martinez- Evaluating the collective evidence, we conclude that
Balbas et al., 2000), and Sp3 (Braun et al., 2001). The ARD1 acetylates Lys532 in the ODD domain of HIF-1
functional consequences of posttranslational modifica- by direct interaction and plays a central role in HIF-1
tion by acetylation of these transcription factors appear stability by accelerating HIF-1 interaction with pVHL.
to be quite varied (Kouzarides, 2000). For instance, the Moreover, our data show that ARD1, as a negative regu-
acetylation of p53, E2F1, and MyoD occurs close to the lator of HIF-1 stability, functions mainly under normoxic
DNA binding domain and results in stimulation of DNA conditions due to the decreased ARD1 mRNA and a
binding (Martinez-Balbas et al., 2000; Sartorelli et al., decreased affinity to HIF-1 under hypoxia. Therefore,
1999; Huang et al., 2000). So far, functions for EKLF and the results reported here establish a key mechanism
TCF acetylation have not been established (Bannister
for the modulation of HIF-1 protein stability through
and Miska, 2000).
acetylation.
Our results suggest that the HIF-1 protein is acet-
ylated and that this modification is essential to the regu- Experimental Procedures
lation of HIF-1 stability. The level of acetylation of HIF-
1 was shown to gradually decrease as the length of Materials
Sodium butyrate (NaBu) and trichostatin A (TSA) were purchasedhypoxic exposure time increases, which we found is
from Sigma and MG132 from Calbiochem. HIF-1 antibody waspartly due to the reduced expression of ARD1. Further,
kindly provided by Dr. J.W. Park (College of Medicine, Seoul Nationalwe showed ARD1 acetylates Lys532 in the ODD domain
University, Seoul, Korea). pVHL, Flag, and GFP antibodies wereof HIF-1 by transferring acetyl group from Ac-CoA. The
purchased from Pharmigen, Sigma, and CLONTECH, respectively.
ODD domain encompasses sequences that mediate O2- p53 and Ac-Lys antibodies were purchased from Upstate Biotech-
dependent ubiquitination of HIF-1 protein (Sutter et al., nology. Multiple Tissue Northern (MTN) blot was purchased from
2000) through the interaction with pVHL, which is the CLONTECH.
E3 ubiquitin-protein ligase (Cockman et al., 2000; Ka-
Plasmids and Recombinant Proteinsmura et al., 2000) that targets HIF-1 for proteasomal
The full-length ARD1 expression vector was constructed by PCRdegradation (Salceda and Caro, 1997). Binding of pVHL
and subcloned into pCMV-Tag (Stratagene). To construct antisenseis dependent on hydroxylation of Pro402 and Pro564 in
ARD1 vector, ARD1 cDNA fragment (1–308) was inserted into
the ODD domain of HIF-1 through an enzymatic pro- pCDNA3.1 (Invitrogen) in reverse orientation. To construct pET-
cess that requires O2 as well as iron and is inhibited by ARD1 and GST-ARD1 for in vitro translation and bacterial induction,
cobalt chloride (Ivan et al., 2001; Jaakkola et al., 2001; the ARD1 cDNA was inserted into pET-28 (Novagene) and pGEX-
4T (Amersham Pharmacia Biotech). For luciferase assay, pBOS-Masson et al., 2001). Here, we report that the acetylation
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hHIF-1, pBOS-hARNT, and pSV40pro-EpoHRE-Luc vectors were Site-Directed Mutagenesis
Site-directed mutagenesies of six lysine residues to arginine in bothkindly provided by Dr. Fujii-Kuriyama (Tohoku University, Japan)
(Ema et al., 1997), and mutated EpoHRE-Luc vector was provided pET-ODD expression vector and Flag-tagged HIF-1 expression
vector were performed using the Quick Change site-directed muta-by Dr. L. Eric Huang (NCI, National Institutes of Health, Bethesda,
MD, USA). pGBT9-ODD, deletion mutants of HIF-1, and GFP-HIF- genesis kit (Stratagene).
1 vectors were prepared as previously described (Bae et al., 2002).
For production of His fusion proteins, pET-ARD1 and pET-ODD In-Gel Digestion and Mass Spectrometric Analysis
vectors were transformed and His-ARD1 and His-ODD proteins were The acetylated ODD protein was excised from Coomassie-stained
purified on a Talon metal affinity column (CLONTECH) according to gel and purified as described (Song et al., 2000). Peptide mixtures
the instructions of the manufacturer. All proteins were dialyzed using were analyzed with MALDI-TOF MS using a delayed ion extraction
Sephadex G-25 column (Amersham Pharmacia Biotech). and ion mirror reflector mass spectrometer (Voyager-DE STR; Ap-
plied Biosystems, Inc.). For interpretation of the mass spectra, we
used the MS-Digest program available on the World Wide Web siteTwo-Hybrid Library Screening and Evaluation
of the University of California at San Francisco (http://prospector.of Protein-Protein Interactions
ucsf.edu).Yeast strains for two-hybrid experiments were obtained from CLON-
TECH as components of the MATCHMAKER Two-hybrid System
VHL-HIF-1 Binding Assay and In Vitro Ubiquitination Assay(CLONTECH). Yeast strains, SFY526 and HF7c, were used to assay
For the binding assay, purified His-ODD protein (1 g) was preincu-protein-protein interactions and for library screening, respectively.
bated with HeLa cell extracts for 2 hr at 30C and then binding assayTwo-hybrid assays using the GAL4 system were performed ac-
was performed as described (Ohh et al., 2000) with [35S]pVHL. Forcording to the instructions of the manufacturer (CLONTECH).
the ubiquitination assay, 35S-labeled ODD (5 l) was incubated in
the presence of HeLa cell extracts (200 g), and the ubiquitinationGST Pull-Down Assay
assay was performed as described (Ohh et al., 2000). For the acetyla-The 35S-labeled deletion mutants of HIF-1 were prepared by TNT
tion-combined experiments, an in vitro acetyltransferase assay wassystem (Promega). GST-fusion proteins were purified as described
preperformed for 2 hr at 30C.(Shuman et al., 1997) and the GST pull-down assay was performed
as described (Bae et al., 2002) using GST or GST-ARD1.
Subcellular Fractionation of Cell Lysates
HT1080 and HT1080-ARD1 cells were incubated in 21% or 1% O2
Cell Culture and Hypoxic Condition for 2 hr and separated into cytoplasmic and nuclear fractions as
HEK293 and HT1080 cells were maintained in DMEM (Invitrogen) described (Kim et al., 1996).
supplemented with 10% fetal bovine serum (Invitrogen) and 1%
antibiotics in a humidified 5% CO2 incubator. For the generation Acknowledgmentsof ARD1-overexpressing cells, HT1080 cells were transfected with
pCMV-ARD1 and selected using G418 (Invitrogen). For the hypoxic
We thank Dr. Fujii-Kuriyama for his gifts of the pBOS-hHIF-1,condition, cells were incubated at a CO2 level of 5% with 1% O2 pBOS-hARNT, and pSV40pro-EpoHRE-Luc vectors; Dr. Jong-Wanbalanced with N2 using a hypoxic chamber (Forma). Park for the anti-HIF-1 antibody; Dr. L. Eric Huang for the mutated
EpoHRE-Luc vector; and Dr. Byung Pal Yu for the critical reading
Coimmunoprecipitation of the manuscript. Financial support was provided by the National
Transiently transfected HEK 293 cells or stably transfected HT1080 Research Laboratory Fund (2001-N-NL-01-C-015), the Ministry of
cells were treated for 6 hr or 2 hr under hypoxic conditions, respec- Science and Technology, Korea (to K.-W.K.).
tively, before harvesting the cells. Preparation of protein extracts,
immunoprecipitation, and Western blot were performed as de- Received: June 3, 2002
scribed previously (Tanimoto et al., 2000). Revised: September 17, 2002
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